Metlife (MET) EBIT Margin (2009 - 2026)

Metlife's EBIT Margin history runs 18 years deep, the most recent figure standing at 44.18% for Q1 2026.

• On a quarterly basis, EBIT Margin rose 1788.0% year-over-year to 44.18% in Q1 2026; TTM through Mar 2026 was 32.6%, a 1762.0% decrease from a year earlier, with the FY2025 full-year figure at 29.27%, down 1807.0% from the prior year.
• EBIT Margin grew to 44.18% in Q1 2026 per MET's latest filing, from 24.88% in the prior quarter.
• Across five years, EBIT Margin topped out at 54.07% in Q1 2024 and bottomed at 73.29% in Q4 2024.
• The 5-year median for EBIT Margin is 28.6% (2022), against an average of 27.22%.
• Across the five-year window, EBIT Margin sank 10149 bps in 2024 and jumped 9816 bps in 2025, its largest moves.
• Year by year, EBIT Margin stood at 28.6% in 2022, then dropped by 1 bps to 28.2% in 2023, then tumbled by 360 bps to 73.29% in 2024, then soared by 134 bps to 24.88% in 2025, then surged by 78 bps to 44.18% in 2026.
• Per Business Quant, the three latest MET EBIT Margin figures stand at 44.18% (Q1 2026), 24.88% (Q4 2025), and 35.07% (Q3 2025).